SEC 13F Intelligence

Propel Bio Management, LLC / ZVRA

Propel Bio Management, LLC’s Zevra Therapeutics Inc Position

Does Propel Bio Management, LLC own Zevra Therapeutics Inc (ZVRA)? Yes — 282.4K shares worth $3M (+1.66% of its 13F portfolio) as of Q1 2026, up from 63.7K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
282.4K
% of Portfolio
+1.66%
Quarters Held
7
currently held

Position History ZVRA

Reported value by quarter
Q3 ’24: $1MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $570,600Q4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026282.4K$3M+1.66%
Q4 202563.7K$570,600+0.49%
Q3 2025231.9K$2M+2.21%
Q2 2025231.9K$2M+2.48%
Q1 2025179.9K$1M+1.57%
Q4 2024179.9K$2M+1.49%
Q3 2024179.9K$1M+0.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of ZVRA.